Latest filing published 27 Apr 2007 for BIOSPECIFICS TECHNOLOGIES CORP, €15k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lawrence Dobroff: trading record in brief
Lawrence Dobroff discloses dealings in Biospecifics Technologies Corp to SEC (Form 4). The record holds 4 filings, for trades running from 16 December 2005 to 25 April 2007.
Market trades split into 2 purchases (€22k) and 1 sale (€7,555). On balance, insiders were net buyers of €15k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. In 2007 alone, the filings show 1 purchase and no sales.
The newest entry dates from 27 April 2007: an open-market purchase of €15k, in Biospecifics Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 11 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lawrence Dobroff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,000 shares@ US$1.43Common Stock, $.001 par valueSEC:0000950120-07-000278:0Canonical exit: 24 Jul 2007 (T+90)
- 10,000 shares@ US$1.50Common StockSEC:0000950120-06-000506:0
- 10,000 shares@ US$0.96BioSpecifics Technologies CorpSEC:0001116502-06-001532:0
- 10,000 shares@ US$0.90Common StockSEC:0001311547-06-000001:0Canonical exit: 5 Jun 2006 (T+90)
4 of 4 declarations